Happy St. Patrick’s Day, again.  See this morning’s post with some wee silliness on that.
A quick newsflash on this lovely green day: this morning Medtronic has announced that it has received FDA approval for its new Paradigm Revel combination insulin pump/continuous glucose monitor, which they’re calling “the industry’s most advanced integrated system for diabetes [...]

Read more »

Following my series of interviews with Kris Freeman, I got a note from competitive cyclist Phil Southerland, founder of Team Type 1.  He wanted to let me know how well his group of athletes with type 1 diabetes have been performing so far this year.
Phil was concerned that the mainstream media coverage of Freeman’s challenges [...]

Read more »

When the  JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.

Usage Issues
Q) How much more [...]

Read more »

Very big news in the diabetes world today, Folks: the Juvenile Diabetes Research Foundation (JDRF) has announced a partnership with insulin pump makers Animas Corp. (a Johnson & Johnson company) to actually start building the first ready-for-market artificial pancreas, i.e. “a fully automated system to dispense insulin … based on real-time changes in blood sugar [...]

Read more »

Last week I learned of yet another company, Echo Therapuetics out of the Boston area, that is developing a transdermal continuous glucose monitoring system for people with diabetes. Naturally that means a non-invasive monitor that takes constant readings through your skin.
Been there. Heard that. Right?
Well, allow me to briefly introduce their work before we get [...]

Read more »